The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
The SARS-CoV-2 main protease as drug target
Open accessAbstract
Graphical abstract
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,828
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
WebLogo: A Sequence Logo Generator: Figure 1
Crooks, G. E., Hon, G., Chandonia, J.-M., & Brenner, S. E. (2004) · Genome Research · doi:10.1101/gr.849004 · Cited by 12,386
A new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688
An interactive web-based dashboard to track COVID-19 in real time
Dong, E., Du, H., & Gardner, L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30120-1 · Cited by 10,048
Chan, J. F.-W., Yuan, S., Kok, K.-H., To, K. K.-W., Chu, H., Yang, J., Xing, F., Liu, J., Yip, C. C.-Y., Poon, R. W.-S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,944
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses, Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0695-z · Cited by 8,403
A novel coronavirus outbreak of global health concern
Wang, C., Horby, P. W., Hayden, F. G., & Gao, G. F. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30185-9 · Cited by 7,700
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., Zhang, L., et al. (2020) · Nature · doi:10.1038/s41586-020-2180-5 · Cited by 5,983
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Origin and evolution of pathogenic coronaviruses
Cui, J., Li, F., & Shi, Z.-L. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0118-9 · Cited by 5,515
On the size of the active site in proteases. I. Papain
Schechter, I., & Berger, A. (1967) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(67)80055-x · Cited by 5,204
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,187
The proximal origin of SARS-CoV-2
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0820-9 · Cited by 5,081
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2223-y · Cited by 4,358
Emerging coronaviruses: Genome structure, replication, and pathogenesis
Chen, Y., Liu, Q., & Guo, D. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25681 · Cited by 3,062
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
Su, S., Wong, G., Shi, W., Liu, J., Lai, A. C. K., Zhou, J., Liu, W., Bi, Y., & Gao, G. F. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.03.003 · Cited by 2,948
Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020) · Science · doi:10.1126/science.abb3405 · Cited by 2,895
Wilder-Smith, A., & Freedman, D. O. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa020 · Cited by 2,727
Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., Wang, Q., Xu, Y., Li, M., Li, X., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.02.008 · Cited by 2,330
Coronavirus Infections—More Than Just the Common Cold
Paules, C. I., Marston, H. D., & Fauci, A. S. (2020) · JAMA · doi:10.1001/jama.2020.0757 · Cited by 2,136
The Molecular Biology of Coronaviruses
Masters, P. S. (2006) · Advances in Virus Research · doi:10.1016/s0065-3527(06)66005-3 · Cited by 1,761
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Li, G., & De Clercq, E. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00016-0 · Cited by 1,729
Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS Drugs
Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., & Hilgenfeld, R. (2003) · Science · doi:10.1126/science.1085658 · Cited by 1,728
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2090 · Cited by 1,661
Developing Covid-19 Vaccines at Pandemic Speed
Lurie, N., Saville, M., Hatchett, R., & Halton, J. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2005630 · Cited by 1,557
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Dai, W., Zhang, B., Jiang, X.-M., Su, H., Li, J., Zhao, Y., Xie, X., Jin, Z., Peng, J., Liu, F., et al. (2020) · Science · doi:10.1126/science.abb4489 · Cited by 1,478
Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak
Zhang, T., Wu, Q., & Zhang, Z. (2020) · Current Biology · doi:10.1016/j.cub.2020.03.022 · Cited by 1,397
The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China
Lau, H., Khosrawipour, V., Kocbach, P., Mikolajczyk, A., Schubert, J., Bania, J., & Khosrawipour, T. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa037 · Cited by 1,294
From SARS to MERS, Thrusting Coronaviruses into the Spotlight
Song, Z., Xu, Y., Bao, L., Zhang, L., Yu, P., Qu, Y., Zhu, H., Zhao, W., Han, Y., & Qin, C. (2019) · Viruses · doi:10.3390/v11010059 · Cited by 1,265
COVID-19, SARS and MERS: are they closely related?
Petrosillo, N., Viceconte, G., Ergonul, O., Ippolito, G., & Petersen, E. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.03.026 · Cited by 1,108
Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control Covid-19
Gandhi, M., Yokoe, D. S., & Havlir, D. V. (2020) · New England Journal of Medicine · doi:10.1056/nejme2009758 · Cited by 1,094
The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China
Yang, Y., Peng, F., Wang, R., Guan, K., Jiang, T., Xu, G., Sun, J., & Chang, C. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102434 · Cited by 1,068
Chemistry: Chemical con artists foil drug discovery
Baell, J., & Walters, M. A. (2014) · Nature · doi:10.1038/513481a · Cited by 1,043
Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants
Tahir ul Qamar, M., Alqahtani, S. M., Alamri, M. A., & Chen, L.-L. (2020) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2020.03.009 · Cited by 1,032
Virus-encoded proteinases and proteolytic processing in the Nidovirales
Ziebuhr, J., Gorbalenya, A. E., & Snijder, E. J. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-4-853 · Cited by 1,029
Yang, H., Yang, M., Ding, Y., Liu, Y., Lou, Z., Zhou, Z., Sun, L., Mo, L., Ye, S., Pang, H., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1835675100 · Cited by 990
Cross‐species transmission of the newly identified coronavirus 2019‐nCoV
Ji, W., Wang, W., Zhao, X., Zai, J., & Li, X. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25682 · Cited by 942
Coronavirus Genomics and Bioinformatics Analysis
Woo, P. C. Y., Huang, Y., Lau, S. K. P., & Yuen, K.-Y. (2010) · Viruses · doi:10.3390/v2081803 · Cited by 913
Ma, C., Sacco, M. D., Hurst, B., Townsend, J. A., Hu, Y., Szeto, T., Zhang, X., Tarbet, B., Marty, M. T., Chen, Y., et al. (2020) · Cell Research · doi:10.1038/s41422-020-0356-z · Cited by 880
Báez-Santos, Y. M., St. John, S. E., & Mesecar, A. D. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2014.12.015 · Cited by 854
Mechanisms and enzymes involved in SARS coronavirus genome expression
Thiel, V., Ivanov, K. A., Putics, Á., Hertzig, T., Schelle, B., Bayer, S., Weißbrich, B., Snijder, E. J., Rabenau, H., Doerr, H. W., et al. (2003) · Journal of General Virology · doi:10.1099/vir.0.19424-0 · Cited by 848
Genomic characterization of a novel SARS-CoV-2
Khailany, R. A., Safdar, M., & Ozaslan, M. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100682 · Cited by 847
A Genomic Perspective on the Origin and Emergence of SARS-CoV-2
Zhang, Y.-Z., & Holmes, E. C. (2020) · Cell · doi:10.1016/j.cell.2020.03.035 · Cited by 818
Morse, J. S., Lalonde, T., Xu, S., & Liu, W. R. (2020) · ChemBioChem · doi:10.1002/cbic.202000047 · Cited by 776
Pillaiyar, T., Manickam, M., Namasivayam, V., Hayashi, Y., & Jung, S.-H. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01461 · Cited by 775
Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases
Yang, H., Xie, W., Xue, X., Yang, K., Ma, J., Liang, W., Zhao, Q., Zhou, Z., Pei, D., Ziebuhr, J., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030324 · Cited by 727
The 2019‐new coronavirus epidemic: Evidence for virus evolution
Benvenuto, D., Giovanetti, M., Ciccozzi, A., Spoto, S., Angeletti, S., & Ciccozzi, M. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25688 · Cited by 713
Inhibition of SARS-CoV 3CL protease by flavonoids
Jo, S., Kim, S., Shin, D. H., & Kim, M.-S. (2020) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2019.1690480 · Cited by 685
From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design
Hilgenfeld, R. (2014) · The FEBS Journal · doi:10.1111/febs.12936 · Cited by 660
Liu, J., Zheng, X., Tong, Q., Li, W., Wang, B., Sutter, K., Trilling, M., Lu, M., Dittmer, U., & Yang, D. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25709 · Cited by 620
Bat-to-human: spike features determining ‘host jump’ of coronaviruses SARS-CoV, MERS-CoV, and beyond
Lu, G., Wang, Q., & Gao, G. F. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.06.003 · Cited by 607
Jackson, P. A., Widen, J. C., Harki, D. A., & Brummond, K. M. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00788 · Cited by 588
Zhang, L., Lin, D., Kusov, Y., Nian, Y., Ma, Q., Wang, J., von Brunn, A., Leyssen, P., Lanko, K., Neyts, J., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01828 · Cited by 568
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
Douangamath, A., Fearon, D., Gehrtz, P., Krojer, T., Lukacik, P., Owen, C. D., Resnick, E., Strain-Damerell, C., Aimon, A., Ábrányi-Balogh, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18709-w · Cited by 526
Xie, M., & Chen, Q. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.071 · Cited by 462
Rut, W., Lv, Z., Zmudzinski, M., Patchett, S., Nayak, D., Snipas, S. J., El Oualid, F., Huang, T. T., Bekes, M., Drag, M., et al. (2020) · Science Advances · doi:10.1126/sciadv.abd4596 · Cited by 459
Evolutionary history, potential intermediate animal host, and cross‐species analyses of SARS‐CoV‐2
Li, X., Zai, J., Zhao, Q., Nie, Q., Li, Y., Foley, B. T., & Chaillon, A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25731 · Cited by 434
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur
Jin, Z., Zhao, Y., Sun, Y., Zhang, B., Wang, H., Wu, Y., Zhu, Y., Zhu, C., Hu, T., Du, X., et al. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-0440-6 · Cited by 426
Genomic variance of the 2019‐nCoV coronavirus
Ceraolo, C., & Giorgi, F. M. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25700 · Cited by 397
Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil
Voloch, C. M., Silva F, R. D., de Almeida, L. G. P., Cardoso, C. C., Brustolini, O. J., Gerber, A. L., Guimarães, A. P. D. C., Mariani, D., Costa, R. M. D., Ferreira, O. C., et al. (2020) · doi:10.1101/2020.12.23.20248598 · Cited by 372
From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses
Hilgenfeld, R., & Peiris, M. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.08.015 · Cited by 354
Fan, K., Wei, P., Feng, Q., Chen, S., Huang, C., Ma, L., Lai, B., Pei, J., Liu, Y., Chen, J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310875200 · Cited by 327
Conservation of substrate specificities among coronavirus main proteases
Hegyi, A., & Ziebuhr, J. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-3-595 · Cited by 322
Possible Bat Origin of Severe Acute Respiratory Syndrome Coronavirus 2
Lau, S. K. P., Luk, H. K. H., Wong, A. C. P., Li, K. S. M., Zhu, L., He, Z., Fung, J., Chan, T. T. Y., Fung, K. S. C., & Woo, P. C. Y. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200092 · Cited by 287
Progress and Prospects on Vaccine Development against SARS-CoV-2
Zhang, J., Zeng, H., Gu, J., Li, H., Zheng, L., & Zou, Q. (2020) · Vaccines · doi:10.3390/vaccines8020153 · Cited by 282
SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity
Muramatsu, T., Takemoto, C., Kim, Y.-T., Wang, H., Nishii, W., Terada, T., Shirouzu, M., & Yokoyama, S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601327113 · Cited by 274
Mechanism of the Maturation Process of SARS-CoV 3CL Protease
Hsu, M.-F., Kuo, C.-J., Chang, K.-T., Chang, H.-C., Chou, C.-C., Ko, T.-P., Shr, H.-L., Chang, G.-G., Wang, A. H.-J., & Liang, P.-H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502577200 · Cited by 262
Molecular biology of severe acute respiratory syndrome coronavirus
Ziebuhr, J. (2004) · Current Opinion in Microbiology · doi:10.1016/j.mib.2004.06.007 · Cited by 241
The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century
da Costa, V. G., Moreli, M. L., & Saivish, M. V. (2020) · Archives of Virology · doi:10.1007/s00705-020-04628-0 · Cited by 217
3C-like Proteinase from SARS Coronavirus Catalyzes Substrate Hydrolysis by a General Base Mechanism
Huang, C., Wei, P., Fan, K., Liu, Y., & Lai, L. (2004) · Biochemistry · doi:10.1021/bi036022q · Cited by 215
Jacobs, J., Grum-Tokars, V., Zhou, Y., Turlington, M., Saldanha, S. A., Chase, P., Eggler, A., Dawson, E. S., Baez-Santos, Y. M., Tomar, S., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301580n · Cited by 200
Asymptomatic and Human-to-Human Transmission of SARS-CoV-2 in a 2-Family Cluster, Xuzhou, China
Li, C., Ji, F., Wang, L., Wang, L., Hao, J., Dai, M., Liu, Y., Pan, X., Fu, J., Li, L., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200718 · Cited by 198
Grum-Tokars, V., Ratia, K., Begaye, A., Baker, S. C., & Mesecar, A. D. (2008) · Virus Research · doi:10.1016/j.virusres.2007.02.015 · Cited by 190
Proteases and protease inhibitors in infectious diseases
Agbowuro, A. A., Huston, W. M., Gamble, A. B., & Tyndall, J. D. A. (2018) · Medicinal Research Reviews · doi:10.1002/med.21475 · Cited by 186
Drug Design Targeting the Main Protease, the Achilles Heel of Coronaviruses
Yang, H., Bartlam, M., & Rao, Z. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206779010369 · Cited by 185
Asymptomatic SARS Coronavirus Infection among Healthcare Workers, Singapore
Wilder-Smith, A., Teleman, M. D., Heng, B. H., Earnest, A., Ling, A. E., & Leo, Y. S. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1107.041165 · Cited by 176
Bzówka, M., Mitusińska, K., Raczyńska, A., Samol, A., Tuszyński, J. A., & Góra, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093099 · Cited by 171
Su, H., Yao, S., Zhao, W., Li, M., Liu, J., Shang, W., Xie, H., Ke, C., Gao, M.-N., Yu, K., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.13.038687 · Cited by 143
Zoonotic origins of human coronavirus 2019 (HCoV-19 / SARS-CoV-2): why is this work important?
Wong, G., Bi, Y., Wang, Q.-H., Chen, X.-W., Zhang, Z., & Yao, Y. (2020) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2020.031 · Cited by 128
Zhu, L., George, S., Schmidt, M. F., Al‐Gharabli, S., Rademann, J., & Hilgenfeld, R. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.08.001 · Cited by 125
The N-terminal octapeptide acts as a dimerization inhibitor of SARS coronavirus 3C-like proteinase
Wei, P., Fan, K., Chen, H., Ma, L., Huang, C., Tan, L., Xi, D., Li, C., Liu, Y., Cao, A., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.102 · Cited by 101
Al‐Tawfiq, J. A., & Gautret, P. (2018) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2018.12.003 · Cited by 99
Characterization and Inhibition of SARS-Coronavirus Main Protease
Liang, P. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606776287090 · Cited by 98
Controversial treatments: An updated understanding of the coronavirus disease 2019
Zhang, C., Huang, S., Zheng, F., & Dai, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25788 · Cited by 97
Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide
Du, Q., Wang, S.-Q., Zhu, Y., Wei, D., Guo, H., Sirois, S., & Chou, K. (2004) · Peptides · doi:10.1016/j.peptides.2004.06.018 · Cited by 94
The substrate specificity of SARS coronavirus 3C-like proteinase
Fan, K., Ma, L., Han, X., Liang, H., Wei, P., Liu, Y., & Lai, L. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.061 · Cited by 90
Lim, L., Shi, J., Mu, Y., & Song, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101941 · Cited by 84
Failure in initial stage containment of global COVID‐19 epicenters
Khosrawipour, V., Lau, H., Khosrawipour, T., Kocbach, P., Ichii, H., Bania, J., & Mikołajczyk, A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25883 · Cited by 84
Schmidt, M. F., Isidro‐Llobet, A., Lisurek, M., El‐Dahshan, A., Tan, J., Hilgenfeld, R., & Rademann, J. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200704594 · Cited by 73
Ho, B.-L., Cheng, S., Shi, L., Wang, T.-Y., Ho, K.-I., & Chou, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144865 · Cited by 67
Muramatsu, T., Kim, Y., Nishii, W., Terada, T., Shirouzu, M., & Yokoyama, S. (2013) · FEBS Journal · doi:10.1111/febs.12222 · Cited by 59
Recent Advances in Targeting Viral Proteases for the Discovery of Novel Antivirals
Steuber, H., & Hilgenfeld, R. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610790725470 · Cited by 57
Development of Small-Molecule MERS-CoV Inhibitors
Liang, R., Wang, L., Zhang, N., Deng, X., Su, M., Su, Y., Hu, L., He, C., Ying, T., Jiang, S., et al. (2018) · Viruses · doi:10.3390/v10120721 · Cited by 53
Fibrinolysis Inhibitors: Potential Drugs for the Treatment and Prevention of Bleeding
Steinmetzer, T., Pilgram, O., Wenzel, B. M., & Wiedemeyer, S. J. A. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01060 · Cited by 33
Homology Models of Coronavirus 2019-nCoV 3CLpro ProteasePreprint
Stoermer, M. J. (2020) · ChemRxiv · doi:10.26434/chemrxiv.11637294.v3 · Cited by 20
Homology Models of Coronavirus 2019-nCoV 3CLpro ProteasePreprint
Stoermer, M. J. (2020) · ChemRxiv · doi:10.26434/chemrxiv.11637294 · Cited by 15
Cited by
Unoh, Y., Uehara, S., Nakahara, K., Nobori, H., Yamatsu, Y., Yamamoto, S., Maruyama, Y., Taoda, Y., Kasamatsu, K., Suto, T., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00117 · Cited by 598
Sacco, M. D., Ma, C., Lagarias, P., Gao, A., Townsend, J. A., Meng, X., Dube, P., Zhang, X., Hu, Y., Kitamura, N., et al. (2020) · Science Advances · doi:10.1126/sciadv.abe0751 · Cited by 385
Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
Mengist, H. M., Dilnessa, T., & Jin, T. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.622898 · Cited by 302
Ma, C., Tan, H., Choza, J., Wang, Y., & Wang, J. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.10.026 · Cited by 86
Metadata
- Authors
- Ullrich, S., & Nitsche, C.
- Venue
- Bioorganic & Medicinal Chemistry Letters
- Publisher
- Elsevier BV
- Published
- 2020-09
- Volume
- 30
- Issue
- 17
- Pages
- 127377
- ISSN
- 0960-894X (ISSN-L)
- OpenAlex
- W3040116040
- Cited by
- 772
- References
- 102
- FWCI
- 17.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.